T cells are capable of killing cancer cells, but tumors have tricks to evade their might. New research details one of these strategies, known as trogocytosis, in which T cells ingest a piece of cancer cell membrane, taking on a bit of cancerous identity. Blocking this process could improve the effectiveness of CAR T cell therapy.